Found: 4
Select item for more details and to access through your institution.
Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myeloma.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 6, p. 889, doi. 10.1111/bjh.13905
- By:
- Publication type:
- Article
An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 6, p. 870, doi. 10.1111/bjh.12838
- By:
- Publication type:
- Article
Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 473, doi. 10.1007/s00262-021-03010-6
- By:
- Publication type:
- Article
SMG1, a nonsense‐mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 2, p. 284, doi. 10.1002/1878-0261.13343
- By:
- Publication type:
- Article